In 2025, the stimulant drug Vyvanse is sold on the street for $3 to $30 per tablet. The price range is due to a number of different variables, such as location of sale, potency of the drug, dosage, local laws, and other factors. A person could reasonably expect to pay $10 for a 50 mg Vyvanse pill on the street.
The average cost of prescription drugs sold on the street is typically based on how easy they are to acquire, local law enforcement, location, and other considerations.
How Much Does Vyvanse Cost On The Street?
Vyvanse comes in 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg doses. The higher the milligram, the more a drug dealer can charge for the pill.
Factors That Affect Vyvanse Street Cost
Vyvanse (lisdexamfetamine) is a Schedule II stimulant medication primarily prescribed for ADHD and binge eating disorder. As a prodrug that requires metabolic conversion to become active, it was designed to have lower abuse potential than other stimulants. However, it still enters illicit markets, particularly among students and professionals seeking cognitive enhancement.
Factors affecting illicit Vyvanse prices:
- Academic Calendar Influence: prices typically spike during exam periods and the beginning of school semesters
- Dosage Strength: higher doses (50mg, 60mg, 70mg) generally command higher prices than starter doses (20mg, 30mg)
- Geographic Concentration: college towns and areas with high student populations see more consistent markets
- Tamper-Resistant Properties: cannot be effectively crushed or injected, limiting appeal to some users and affecting pricing
- Prescription Accessibility: requires specialist diagnosis for ADHD, creating a more limited legitimate supply than some other medications
- Competition From Other Stimulants: Adderall and other amphetamines may offer more immediate effects, impacting Vyvanse demand
- Professional vs Recreational Markets: different pricing for students seeking study aids versus recreational users
- Insurance Coverage Patterns: high legitimate costs can drive diversion when people can’t afford prescriptions
- Duration of Effect: longer-acting formulation appeals to some users but may limit others seeking shorter effects
- Law Enforcement Awareness: generally less targeted than opioids, potentially affecting availability
The illicit Vyvanse market reflects both its intended design features and unintended consequences. While its prodrug mechanism reduces some forms of abuse, it remains valuable in markets focused on cognitive enhancement rather than euphoria. The cyclical demand patterns tied to academic schedules highlight how prescription stimulant abuse often differs from traditional drug markets, requiring prevention approaches that address both legitimate medical needs and misuse in educational and professional settings.
Vyvanse is expensive at the pharmacy. Out-of-pocket cost, without insurance, can be upwards of $400 for a 30-day supply, or $13.33 per pill. With insurance, the cost can sometimes drop to $0.
To learn about substance abuse treatment programs in your area, reach out to your primary care provider or talk to an addiction specialist today.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- National Institutes of Health — Comparative Effectiveness Review Summary Guides for Consumers
https://www.ncbi.nlm.nih.gov/books/NBK99163/table/consadhd.tu3/ - National Institutes of Health — University Students Perceptions about motives for and consequences of non-medical use of prescription drugs (NMUPD)
https://pmc.ncbi.nlm.nih.gov/articles/PMC7874525/
